Table 1.
Variables | |
---|---|
Age (years) | 71.5 (64.9–76.7)a |
Male/female (cases) | 101/17 |
Disease (cases) renal cell cancer/urothelial cancer/prostate cancer | 22/27/69 |
First-line bone-modifying agent (case) | |
Zoledronic acid | 57 |
Denosumab | 61 |
aNumbers represent median (IQR)